Innovations in Care
We provide programs and services that transform the lives of people affected by neuromuscular disease.
A Closer Look at Twice-Yearly UPLIZNA
June 9th, 2026
12:00 PM EST
30 minutes
Live, Virtual Webinar
Please join us to learn more about Uplizna as a treatment option for adults with Generalized Myasthenia Gravis (gMG) who are either anti-AChR antibody positive or anti-MuSK antibody positive, and the MINT Study and its results during this webinar.
If you have questions or comments, contact mdapartners@mdausa.org. For more community educational programs and resources, please visit Community Industry Update Webinars.
Thank you to our supporter:
